<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5890">
  <stage>Registered</stage>
  <submitdate>27/04/2016</submitdate>
  <approvaldate>27/04/2016</approvaldate>
  <nctid>NCT02772380</nctid>
  <trial_identification>
    <studytitle>Acute Study to Collect Electrical Signals From the Heart Using a Special Lead</studytitle>
    <scientifictitle>Acute Extravascular Defibrillation Study</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>U1111-1179-2213</secondaryid>
    <secondaryid>ASD2</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Tachycardia</healthcondition>
    <healthcondition>Ventricular Arrhythmias</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Defibrillation following induction of VT/VF

Experimental: VT/ VF induction and defibrillation - Ventricular Tachycardia and Ventricular Fibrillation (VT/VF) induction and termination through use of a defibrillator, will be carried out as the intervention in all subjects undergoing study procedures.


Treatment: devices: Defibrillation following induction of VT/VF
Up to 10 attempts to induce two VF/VT episodes for defibrillation testing

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Number of extravascular electrograms collected during ventricular fibrillation or ventricular tachycardia episodes - Collect extravascular EGMs during induced VF/VT and intrinsic rhythms directly from an investigational lead placed in the extravascular space to be used for development of a future ICD.</outcome>
      <timepoint>Day of procedure</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Subject must be undergoing surgical procedure for approved indications for:

               -  cardiothoracic surgery where a midline sternotomy is planned, or

               -  cardiothoracic surgery where a subxiphoid/paraxiphoid cut for a chest tube is
                  planned, or

               -  VT ablation procedure with epicardial access, or

               -  implant of a subcutaneous ICD (S-ICD®), or implant of a transvenous ICD (single
                  or dual chamber)

          -  Subject must be willing to provide Informed Consent

          -  Subject must be = 18 years old</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Subject has known hiatus hernia or moderate or worse pectus excavatum

          -  Subject had previous pericarditis or prior sternotomy

          -  Subject has known significant Right Ventricle/ Right Ventricular dilation

          -  Subject has hypertrophic cardiomyopathy

          -  Subject is pacemaker dependent

          -  Subject has known skin irritations due to the Covidien Multi-function defibrillation
             electrode

          -  Subject is considered to be at high risk for infection(1)

          -  Subject has Left Ventricular Ejection Fraction &lt; 20% (most recent available LVEF
             measurement in the last 6 months)

          -  Subject has New York Heart Association Class IV

          -  Subject has myocardial infarction within the last 6 weeks

          -  Subject currently has unstable angina

          -  Subject has severe aortic stenosis

          -  Subject at high risk of stroke (2)

          -  Subject has Chronic Obstructive Pulmonary Disease and is oxygen dependent

          -  Subject has permanent AF and will not be adequately anticoagulated during the ASD2
             Acute Testing procedure (3)

          -  Subject with an implanted active cardiac or non-cardiac device during the ASD2 Acute
             Testing procedure (e.g., ICD, S-ICD®, Pacemaker, Neuro stimulator)

          -  Subject is enrolled in a concurrent study that may confound the results of this study,
             without documented pre-approval from a Medtronic study manager

          -  Subject has any medical condition that would limit study participation

          -  Subject is pregnant, or of childbearing potential and not on a reliable form of birth
             control. Women of childbearing potential are required to have a negative pregnancy
             test within 7 days prior to the ASD2 Acute Testing procedure

          -  Subject meets exclusion criteria required by local law (e.g. age, breast feeding,etc.)

          -  Subject is legally incompetent

               1. Screening subjects at high risk for infection will be based on the local
                  investigator judgment decision.

               2. Subjects who are at high risk for stroke should be screened according to local
                  country guidelines or, in case of their absence, according to ACC/AHA/ESC 2006
                  Guidelines for High Risk Factors for Stroke (i.e. exclusion of subjects with
                  previous stroke, TIA, or embolism; Mitral stenosis; prosthetic heart valve).

               3. Screening will be based on the local investigator judgment decision.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Other</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate />
    <actualstartdate>1/05/2016</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>120</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/08/2017</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Austin Hospital - Heidelberg</hospital>
    <postcode> - Heidelberg</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Arizona</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Connecticut</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Florida</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Illinois</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Iowa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Maryland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Minnesota</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New Jersey</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New York</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>North Carolina</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Ohio</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Pennsylvania</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>Gent</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>Leuven</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>British Columbia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Ontario</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Quebec</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hong Kong</country>
      <state>Kowloon</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Budapest</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Amsterdam</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Maastricht</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Nieuwegein</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Christchurch</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Kraków</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Poland</country>
      <state>Zabrze</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Cordoba</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>Taichung</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Taiwan</country>
      <state>Taipei</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Liverpool</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>London</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Oxford</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Southampton</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Medtronic Cardiac Rhythm and Heart Failure</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The main purpose of this clinical study is to collect electrograms from an investigational
      lead placed in an extravascular space, for development of a future Implantable Cardioverter
      Defibrillator (ICD) system.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02772380</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>